Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects

Almilaji, 2012, Regulation of the glutamate transporter EAAT3 by mammalian target of rapamycin mTOR, Biochem Biophys Res Commun, 421, 159, 10.1016/j.bbrc.2012.03.109 Altar, 2004, Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways, J Neurosci, 24, 2667, 10.1523/JNEUROSCI.5377-03.2004 Altshuler, 2008, Regional brain changes in bipolar I depression: a functional magnetic resonance imaging study, Bipolar Disord, 10, 708, 10.1111/j.1399-5618.2008.00617.x Banasr, 2011, Cell atrophy and loss in depression: reversal by antidepressant treatment, Curr Opin Cell Biol, 23, 730, 10.1016/j.ceb.2011.09.002 Berkich, 2007, Mitochondrial transport proteins of the brain, J Neurosci Res, 85, 3367, 10.1002/jnr.21500 Castren, 2007, Role of neurotrophic factors in depression, Curr Opin Pharmacol, 7, 18, 10.1016/j.coph.2006.08.009 Chadborn, 2006, PTEN couples Sema3A signalling to growth cone collapse, J Cell Sci, 119, 951, 10.1242/jcs.02801 Chandran, 2012, Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress, Prog Neuropsychopharmacol Biol Psychiatry, 40, 240, 10.1016/j.pnpbp.2012.08.001 Chen, 1988, Immune labeling and purification of a 71-kDa glutamate-binding protein from brain synaptic membranes. Possible relationship of this protein to physiologic glutamate receptors, J Biol Chem, 263, 417, 10.1016/S0021-9258(19)57409-9 Choudary, 2005, Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression, Proc Natl Acad Sci U S A, 102, 15653, 10.1073/pnas.0507901102 Coyle, 2003, Finding the intracellular signaling pathways affected by mood disorder treatments, Neuron, 38, 157, 10.1016/S0896-6273(03)00195-8 Deschwanden, 2011, Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study, Am J Psychiatry, 168, 727, 10.1176/appi.ajp.2011.09111607 Dreher, 2008, Damage to the fronto-polar cortex is associated with impaired multitasking, PLoS One, 3, e3227, 10.1371/journal.pone.0003227 Duman, 2006, A neurotrophic model for stress-related mood disorders, Biol Psychiatry, 59, 1116, 10.1016/j.biopsych.2006.02.013 Eaton, 1990, Immunochemical characterization of brain synaptic membrane glutamate-binding proteins, J Biol Chem, 265, 16195, 10.1016/S0021-9258(17)46207-7 Eickholt, 2002, An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling, J Cell Biol, 157, 211, 10.1083/jcb.200201098 Elfving, 2010, Differential brain, but not serum VEGF levels in a genetic rat model of depression, Neurosci Lett, 474, 13, 10.1016/j.neulet.2010.02.063 Endicott, 1978, A diagnostic interview: the schedule for affective disorders and schizophrenia, Arch Gen Psychiatry, 35, 837, 10.1001/archpsyc.1978.01770310043002 Evans, 2004, Dysregulation of the fibroblast growth factor system in major depression, Proc Natl Acad Sci U S A, 101, 15506, 10.1073/pnas.0406788101 Fernandez, 2007, Lifeguard/neuronal membrane protein 35 regulates Fas ligand-mediated apoptosis in neurons via microdomain recruitment, J Neurochem, 103, 190 Feyissa, 2009, Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression, Prog Neuropsychopharmacol Biol Psychiatry, 33, 70, 10.1016/j.pnpbp.2008.10.005 Fiermonte, 2002, Identification of the mitochondrial glutamate transporter. Bacterial expression, reconstitution, functional characterization, and tissue distribution of two human isoforms, J Biol Chem, 277, 19289, 10.1074/jbc.M201572200 First, 1996, Nosology of chronic mood disorders, Psychiatr Clin North Am, 19, 29, 10.1016/S0193-953X(05)70271-9 Gaughran, 2006, Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder, Brain Res Bull, 70, 221, 10.1016/j.brainresbull.2006.04.008 Geiss, 2008, Direct multiplexed measurement of gene expression with color-coded probe pairs, Nat Biotechnol, 26, 317, 10.1038/nbt1385 Geretti, 2008, Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis, Angiogenesis, 11, 31, 10.1007/s10456-008-9097-1 Gould, 2004, AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test, Int J Neuropsychopharmacol, 7, 387, 10.1017/S1461145704004535 Gould, 2006, Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders, Curr Drug Targets, 7, 1399, 10.2174/1389450110607011399 Gubser, 2007, A new inhibitor of apoptosis from vaccinia virus and eukaryotes, PLoS Pathog, 3, e17, 10.1371/journal.ppat.0030017 Heine, 2005, Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk-1 protein expression, Eur J Neurosci, 21, 1304, 10.1111/j.1460-9568.2005.03951.x Hollmann, 1994, Cloned glutamate receptors, Annu Rev Neurosci, 17, 31, 10.1146/annurev.ne.17.030194.000335 Hu, 2009, LFG: a candidate apoptosis regulatory gene family, Apoptosis, 14, 1255, 10.1007/s10495-009-0402-2 Itoh, 2011, Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease, J Biochem, 149, 121, 10.1093/jb/mvq121 Jernigan, 2011, The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder, Prog Neuropsychopharmacol Biol Psychiatry, 35, 1774, 10.1016/j.pnpbp.2011.05.010 Jope, 2011, Glycogen synthase kinase-3 in the etiology and treatment of mood disorders, Front Mol Neurosci, 4, 16, 10.3389/fnmol.2011.00016 Karege, 2007, Alteration in kinase activity but not in protein levels of protein kinase B and glycogen synthase kinase-3beta in ventral prefrontal cortex of depressed suicide victims, Biol Psychiatry, 61, 240, 10.1016/j.biopsych.2006.04.036 Kawasaki, 1999, A requirement for neuropilin-1 in embryonic vessel formation, Development, 126, 4895, 10.1242/dev.126.21.4895 Kelly, 2001, Disorders of glutamate metabolism, Ment Retard Dev Disabil Res Rev, 7, 287, 10.1002/mrdd.1040 Kim, 2009, Shank 2 expression coincides with neuronal differentiation in the developing retina, Exp Mol Med, 41, 236, 10.3858/emm.2009.41.4.026 Kitsukawa, 1997, Neuropilin–semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice, Neuron, 19, 995, 10.1016/S0896-6273(00)80392-X Kolodkin, 1997, Neuropilin is a semaphorin III receptor, Cell, 90, 753, 10.1016/S0092-8674(00)80535-8 Krishnan, 2008, The molecular neurobiology of depression, Nature, 455, 894, 10.1038/nature07455 Kumar, 1991, Cloning of cDNA for the glutamate-binding subunit of an NMDA receptor complex, Nature, 354, 70, 10.1038/354070a0 Li, 2010, mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists, Science, 329, 959, 10.1126/science.1190287 Lucassen, 2006, Stress, depression and hippocampal apoptosis, CNS Neurol Disord Drug Targets, 5, 531, 10.2174/187152706778559273 Ly, 1991, Solubilization, partial purification, and reconstitution of glutamate- and N-methyl-d-aspartate-activated cation channels from brain synaptic membranes, Biochemistry, 30, 4307, 10.1021/bi00231a029 Mathews, 2012, Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date, Drugs, 72, 1313, 10.2165/11633130-000000000-00000 Miguel-Hidalgo, 2010, Glial and glutamatergic markers in depression, alcoholism, and their comorbidity, J Affect Disord, 127, 230, 10.1016/j.jad.2010.06.003 Monkul, 2012, Abnormal resting state corticolimbic blood flow in depressed unmedicated patients with major depression: a (15)O–H(2)O PET study, Hum Brain Mapp, 33, 272, 10.1002/hbm.21212 Naisbitt, 1999, Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin, Neuron, 23, 569, 10.1016/S0896-6273(00)80809-0 Neufeld, 2002, The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis, Trends Cardiovasc Med, 12, 13, 10.1016/S1050-1738(01)00140-2 Nielsen, 2011, Mouse transmembrane BAX inhibitor motif 3 (Tmbim3) encodes a 38 kDa transmembrane protein expressed in the central nervous system, Mol Cell Biochem, 357, 73, 10.1007/s11010-011-0877-3 Pal, 1999, Immunocytochemical and in situ hybridization studies of the expression and distribution of three subunits of a complex with N-methyl-d-aspartate receptor-like properties, Neuroscience, 94, 1291, 10.1016/S0306-4522(99)00386-3 Pasterkamp, 2009, Semaphorin function in neural plasticity and disease, Curr Opin Neurobiol, 19, 263, 10.1016/j.conb.2009.06.001 Pittenger, 2008, Stress, depression, and neuroplasticity: a convergence of mechanisms, Neuropsychopharmacology, 33, 88, 10.1038/sj.npp.1301574 Pruitt, 2009, NCBI Reference Sequences: current status, policy and new initiatives, Nucleic Acids Res, 37, D32, 10.1093/nar/gkn721 Pruitt, 2012, NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy, Nucleic Acids Res, 40, D130, 10.1093/nar/gkr1079 Puschel, 2002, The function of neuropilin/plexin complexes, Adv Exp Med Biol, 515, 71, 10.1007/978-1-4615-0119-0_6 Richieri, 2011, Predictive value of brain perfusion SPECT for rTMS response in pharmacoresistant depression, Eur J Nucl Med Mol Imaging, 38, 1715, 10.1007/s00259-011-1850-9 Savitz, 2009, Bipolar and major depressive disorder: neuroimaging the developmental–degenerative divide, Neurosci Biobehav Rev, 33, 699, 10.1016/j.neubiorev.2009.01.004 Shelton, 2009, Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls, Int J Neuropsychopharmacol, 12, 1223, 10.1017/S1461145709000285 Shelton, 2011, Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression, Mol Psychiatry, 16, 751, 10.1038/mp.2010.52 Sibson, 1998, Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity, Proc Natl Acad Sci U S A, 95, 316, 10.1073/pnas.95.1.316 Soker, 1998, Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor, Cell, 92, 735, 10.1016/S0092-8674(00)81402-6 Spitzer, 1979 Takahashi, 1999, Plexin–neuropilin-1 complexes form functional semaphorin-3A receptors, Cell, 99, 59, 10.1016/S0092-8674(00)80062-8 Tamagnone, 1999, Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates, Cell, 99, 71, 10.1016/S0092-8674(00)80063-X Tochigi, 2008, Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains, Neurosci Res, 60, 184, 10.1016/j.neures.2007.10.010 Tu, 1999, Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins, Neuron, 23, 583, 10.1016/S0896-6273(00)80810-7 Turner, 2006, The fibroblast growth factor system and mood disorders, Biol Psychiatry, 59, 1128, 10.1016/j.biopsych.2006.02.026 Uezato, 2009, Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia, Bipolar Disord, 11, 711, 10.1111/j.1399-5618.2009.00752.x Warner-Schmidt, 2007, VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants, Proc Natl Acad Sci U S A, 104, 4647, 10.1073/pnas.0610282104 Warner-Schmidt, 2008, VEGF as a potential target for therapeutic intervention in depression, Curr Opin Pharmacol, 8, 14, 10.1016/j.coph.2007.10.013 Xu, 1998, Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast, Mol Cell, 1, 337, 10.1016/S1097-2765(00)80034-9 Zhou, 2008, Comparative genomics and function analysis on BI1 family, Comput Biol Chem, 32, 159, 10.1016/j.compbiolchem.2008.01.002